PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Takeda acquires GammaDelta Therapeutics

Takeda has acquired GammaDelta Therapeutics Limited, a company focused on exploiting the unique properties of gamma delta (??) T cells for immunotherapy. Through ...
Continue Reading →
News

Global vaccine trade surpasses $42 billion

According to a new report published by IndexBox, in the first half of 2021, global vaccine exports were valued at $42.5 billion, a record high over the last decade. ...
Continue Reading →
News

First authorisation for Novavax COVID-19 jab announced

Novavax has received the first emergency use authorisation (EUA) for its COVID-19 vaccine in Indonesia, with the company adding it is expecting further authorisation...
Continue Reading →
News

AZ to transfer certain drug rights to Covis Pharma for $270m

AstraZeneca has announced it will transfer global rights to Eklira (aclidinium bromide) and Duaklir (aclidinium bromide/formoterol) to Covis Pharma Group in a $270m ...
Continue Reading →
News

Nemera launches UniSpray, its unidose system primarily for systemic-acting drug administration

Nemera has a proven track record in developing and manufacturing complex Ear, Nose and Throat solutions. In line with clear growing market interest in unidose system...
Continue Reading →
News

Pfizer and BioNTech announce Phase 3 trial data showing high efficacy of a booster dose of their COVID-19 vaccine

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a ...
Continue Reading →
News

Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it has launched the AVENIO Tumor Tissue CGP Kit. The Kit complements the current CGP portfolio offered by Roche a...
Continue Reading →
News

MHRA licenses Ryeqo for symptoms of uterine fibroids

The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed Gedeon Richter UK’s Ryeqo (relugolix combination therapy) for the treatment of moderate t...
Continue Reading →
News

UK COVID-19 patients able to take GP prescribed medicine at home

COVID sufferers in the UK are now able to access a course of tablets from their GP to avoid the need for hospitalisation. AiPharma’s antiviral treatment, favipiravir...
Continue Reading →
News

NICE does not recommend tucatinib for advanced breast cancer

NICE has published draft guidance for public consultation which does not recommend tucatinib, in combination with trastuzumab and capecitabine, for some types of bre...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026